Pharmaceutical packaging sits at the intersection of regulatory compliance, patient safety, and brand presentation — a combination that most packaging manufacturers are not equipped to handle simultaneously. The carton that holds a prescription medication, an OTC supplement, or a medical device has to meet specific labeling requirements, protect the product from moisture, light, and contamination, and communicate clearly to both healthcare providers and end patients. Working with a qualified pharmaceutical packaging manufacturer means all three of those demands are treated as equally important, not traded off against each other. VSL Packaging produces custom pharmaceutical packaging from New York City for drug manufacturers, compounding pharmacies, biotech firms, and healthcare brands.
Pharmaceutical packaging operates under regulatory frameworks that do not apply to consumer goods. FDA labeling requirements specify what information must appear on the primary and secondary package, in what format, at what minimum type size, and with what prominence. Child-resistant closure requirements under the PPPA govern how certain package formats must function. Tamper-evident features are mandatory for OTC drug products. Serialization and track-and-trace requirements are increasingly standard for prescription products moving through the supply chain. A packaging manufacturer that does not understand these requirements creates compliance exposure for every client they serve.
VSL Packaging works with pharmaceutical clients from the specification stage to ensure that structural and print choices satisfy applicable regulatory requirements before production begins. That means reviewing labeling copy against FDA requirements, specifying child-resistant or tamper-evident features where mandated, and maintaining print file integrity so required text elements print at the correct size and color contrast. For clients also managing apparel packaging or consumer product lines alongside pharmaceutical formats, VSL keeps regulatory and commercial production streams clearly separated to avoid cross-contamination of specifications.
The most common pharmaceutical secondary package is the folding carton — a paperboard structure that holds the primary container (vial, blister pack, bottle, tube) and carries the required labeling information. Folding cartons for pharmaceutical use require tighter dimensional tolerances than standard consumer cartons because they interface with automated filling and packaging equipment that runs at high speed. A carton that is 0.5mm too wide jams the line; one that is too narrow allows the primary container to rattle and potentially break. VSL Packaging produces pharmaceutical folding cartons with the dimensional precision that pharma packaging lines require.
Beyond folding cartons, pharmaceutical packaging includes blister card backing boards, insert leaflets folded to precise specifications, shipper cartons for controlled-environment distribution, and specialty formats for serialization labeling. For products that require cold-chain distribution, board selection and adhesive systems must perform at low temperatures without delaminating or losing structural integrity. VSL's material sourcing and testing protocols address these requirements explicitly, rather than leaving cold-chain performance as an assumption. For clients whose pharmaceutical products also require luxury packaging presentation at the retail or gifting tier, VSL can develop both regulated and premium formats within the same supplier relationship.
Print on pharmaceutical packaging is not evaluated the same way as print on consumer goods. The primary consideration is legibility and compliance — dosage instructions, active ingredients, warnings, and NDC codes must be readable under realistic conditions, including by patients with impaired vision. Secondary considerations include brand differentiation, anti-counterfeiting features, and serialization data matrix codes that must scan reliably throughout the supply chain. VSL Packaging applies pharmaceutical print standards from the earliest proof stages, verifying that small text prints with the crispness and contrast required rather than treating legibility as a secondary review item.
Color management for pharmaceutical cartons is also more demanding than for general consumer packaging. Many drug brands maintain specific Pantone references that appear consistently across packaging, marketing materials, and digital assets. Maintaining those references across production runs — including reorders months or years apart — requires active color management, not just printing to a general specification. VSL uses densitometry and spectrophotometry at press to maintain color fidelity across runs, so a reorder matches the original production run without requiring a separate brand approval cycle. For clients needing a trusted pharmaceutical packaging manufacturer who can handle both compliance-critical and brand-critical print standards simultaneously, VSL's in-house production control provides that assurance.
The Drug Supply Chain Security Act (DSCSA) requires that pharmaceutical products moving through the US supply chain carry unique product identifiers — typically a 2D data matrix barcode — that enable item-level tracking from manufacturer to dispenser. Implementing serialization on packaging requires coordination between the packaging manufacturer, the brand owner's ERP system, and the contract packager or filling line. VSL Packaging works with clients to integrate serialization data into carton artwork without compromising the overall design or creating legibility conflicts with other required label elements.
Anti-counterfeiting features add another layer of complexity. Covert features — UV-reactive inks, microtext, watermarks in the paperboard — are not visible during normal inspection but authenticate under verification conditions. Overt features — holograms, color-shifting inks, tamper-evident labels — are visible and signal authenticity to distributors and patients without requiring special equipment. VSL can incorporate both covert and overt anti-counterfeiting measures into pharmaceutical carton programs, coordinating feature selection with the client's security printing vendor where specialized substrates are required. For clients managing pharmaceutical products alongside commercial packaging at scale, VSL maintains strict separation between serialized pharma production and standard commercial runs.
Pharmaceutical packaging programs are not one-time projects — they are ongoing relationships that extend through product life cycles, label updates, line extensions, and regulatory changes. A drug product approved today may require a label update within the first year if new safety information emerges. A product line extension may require a new carton size that matches the existing family. A reformulation may require updated ingredient listings on the existing carton. Managing these changes requires a supplier who maintains complete specification records, keeps print files current, and can execute changes on timelines that regulatory requirements dictate rather than standard commercial production schedules.
VSL Packaging maintains complete documentation for all pharmaceutical packaging programs: structural specifications, board grades, adhesive systems, print files, color standards, and proof records. When a label change is required, VSL can execute the artwork revision, produce a new proof for regulatory review, and return to production without requiring a full re-specification of the carton. For pharmaceutical brands that also need ongoing sports packaging or consumer product packaging alongside their regulated programs, VSL's account management structure keeps each program's documentation clearly separated and current. The goal is a packaging supplier relationship that matches the durability and precision that pharmaceutical manufacturing demands.